OTLC
Oncotelic Therapeutics Inc

402
Loading...
Loading...
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
40

Frequently Asked Questions

What is Market Cap of Oncotelic Therapeutics Inc?
What is the 52-week high for Oncotelic Therapeutics Inc?
What is the 52-week low for Oncotelic Therapeutics Inc?
What is Oncotelic Therapeutics Inc stock price today?
What was Oncotelic Therapeutics Inc stock price yesterday?
What is the PE ratio of Oncotelic Therapeutics Inc?
What is the Price-to-Book ratio of Oncotelic Therapeutics Inc?
What is the 50-day moving average of Oncotelic Therapeutics Inc?
How many employess does Oncotelic Therapeutics Inc has?

Latest OTLC News

View
No OTLC news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.